Labcorp
Price: 268.63Company and Business Model
Labcorp is a leading healthcare company that provides comprehensive laboratory services and diagnostic solutions. Its core offerings include clinical laboratory testing, drug development services, and genomic testing. The company operates in two major segments: Labcorp Diagnostics and Labcorp Drug Development. Major revenue sources stem from clinical testing services for healthcare providers and pharmaceutical companies, as well as from its extensive portfolio of laboratory tests and clinical trials.
Investment Profile
The investment profile of Labcorp is more aligned with value investors, given its stable revenue generation and modest dividend yield. The stock may appeal to those seeking consistent performance rather than aggressive growth, reflecting a balanced approach to risk and potential returns.
Fundamental metrics (experimental)
- EPS (TTM) — earnings per share for the last 12 months, $
- 11.37 OK
- Revenue QoQ — quarter-over-quarter revenue growth
- 0.6% ≈
- EPS surprise
- 3.0% in line
- 20d volatility
- 1.1% stable
- Dividend yield
- 1.1% moderate last ex-date: 2026-05-29
Track in portfolio
Price chart
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-06-10 00:48 | Hold | Buy | Strong performance and solid fundamentals support growth potential. |
| 2026-05-24 02:44 | Sell | Hold | Mixed performance; cautious outlook amid market conditions. |
| 2026-05-16 02:42 | Hold | Sell | Weak momentum and fundamentals raise significant risk. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-05-01 12:49 | Robert W. Baird | Target Raised | 332 → 334 | 255.97 |
| 2026-04-08 13:14 | Evercore ISI | Target Raised | 280 → 300 | 274.72 |
| 2026-02-24 11:40 | Piper Sandler | Target Raised | 270 → 300 | 285.3 |
Nothing yet